Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. announced a public offering of 4,400,440 subordinate voting shares in the U.S. and Canada, with an option for underwriters to purchase an additional 660,066 shares. The offering is managed by Canaccord Genuity LLC, subject to market conditions and regulatory approvals. Net proceeds will primarily fund business development and general working capital. The registration statement with the SEC is pending effectiveness, and the shares will be offered across Canada, excluding Quebec.
Trulieve Cannabis Corp. has opened its 83rd dispensary in Sebring, Florida, marking a significant expansion in patient access to high-quality medical cannabis. This location is notable as it is the first dispensary in Highlands County. The opening aims to provide better access to medical cannabis as the patient registry surpasses 500,000 in Florida. On opening day, Trulieve will offer a 25% discount for all patients. The new dispensary also supports Trulieve's commitment to education and resources in the community.
Trulieve Cannabis Corp has elevated Eric Powers to Chief Legal Officer and appointed Ronda Sheffield as Chief Human Resources Officer, Zachary Kobrin as General Counsel, and Aaron Lopez as Director of Government Affairs, effective March 15, 2021. These appointments aim to strengthen Trulieve's legal, HR, and government affairs capabilities to better support its national expansion strategy as a leading cannabis brand. With a focus on growth, the new leadership team is poised to enhance organizational effectiveness and compliance within the evolving cannabis industry.
Trulieve Cannabis Corp (OTC: TCNNF) has partnered with Morehouse School of Medicine to advance cannabis research and education. This collaboration will focus on medical cannabis-related research, including a real-world data registry and cannabinoid receptor genetics. Trulieve aims to develop personalized medical cannabis treatments, employee career fairs, and educational offerings. The partnership marks a significant step in understanding cannabis’s potential and effectiveness in medical applications.
Trulieve Cannabis Corp. (OTCQX: TCNNF) has opened two new dispensaries in Central Florida, located in Clearwater and Tampa, marking its 81st and 82nd locations nationwide. These dispensaries provide access to Florida's largest range of medical cannabis products, enhancing patient accessibility. Trulieve now operates 77 dispensaries in Florida. To celebrate the openings, a one-day 25% discount is available for all patients. The company emphasizes safety measures in compliance with health guidelines and has witnessed a growing patient registry nearing 500,000 in Florida.
On February 26, 2021, Trulieve Cannabis Corp (OTC: TCNNF) announced a partnership with the Thurgood Marshall College Fund (TMCF), committing $20,000 for scholarships and $15,000 for internship support. This initiative aims to enhance diversity, equity, and inclusion by providing opportunities for students at Historically Black Colleges and Universities. CEO Kim Rivers emphasized Trulieve's commitment to educational equity, while TMCF expressed gratitude for the support aimed at reducing financial barriers for students pursuing higher education.
Trulieve Cannabis Corp. has opened its 80th dispensary nationwide, marking its 75th location in Florida and its first in Tamarac. This new outlet expands patient access to Florida's largest selection of medical cannabis products. CEO Kim Rivers emphasized the company's commitment to patient care. For the grand opening on February 27, 2021, a 25% in-store discount is offered. Trulieve is a key player in the state's cannabis market, consistently selling approximately half of Florida's medical marijuana volume. The firm operates across multiple states and focuses on a 'seed-to-sale' model.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced CEO Kim Rivers will speak at the Benzinga Cannabis Capital Conference on February 25, 2021, at 3:05 p.m. EST. The event will feature top executives and investors in the cannabis industry. As a leading medical cannabis company, Trulieve operates as a vertically integrated "seed-to-sale" organization, primarily in Florida, and also has a presence in California, Massachusetts, and Connecticut. Trulieve is recognized for cultivating and producing cannabis products in-house and distributing them through its own dispensaries.
Trulieve Cannabis Corp. has announced the opening of its 79th dispensary in Jacksonville, Florida, marking its third location in the area. This new outlet expands patient access to Florida's largest inventory of medical cannabis products, supporting the company's goal of ensuring direct access across the state. With a 25% discount available on opening day for all patients, Trulieve continues to cater to the growing patient base, now exceeding 475,000 registered medical marijuana patients. The company emphasizes safety measures in-store and offers virtual consultations for product guidance.
Trulieve Cannabis Corp. expands its product lineup with the launch of Cold Cure Live Rosin, a premium solventless cannabis extract, in Florida. This product offers enhanced terpene profiles and full-spectrum relief for patients. Cold Cure Live Rosin utilizes ice water extraction techniques, preserving the natural flavors and effects of cannabis. The initial batches will be available in select stores starting February 4, 2021, with plans for statewide availability. The company continues to strengthen its position as a leading cannabis provider, growing its portfolio of high-quality offerings.
FAQ
What is the current stock price of Trulieve Cannabis (TCNNF)?
What is the market cap of Trulieve Cannabis (TCNNF)?
